Turtle Creek Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$33.1M Buy
28,640
+822
+3% +$970K 1.67% 12
2026
Q2
$33.4M Buy
27,818
+2,226
+9% +$2.27M 1.76% 13
2026
Q1
$23.5M Buy
25,592
+994
+4% +$1.01M 1.78% 8
2025
Q4
$26.4M Buy
24,598
+2,142
+10% +$2.05M 2.08% 6
2025
Q3
$17.1M Buy
22,456
+11,741
+110% +$8.74M 1.53% 13
2025
Q2
$8.35M Sell
10,715
-1,281
-11% -$995K 0.99% 29
2025
Q1
$9.9M Buy
+11,996
New +$10M 1.48% 16
2024
Q4
– Sell
-5,243
Closed -$4.64M – 126
2024
Q3
$4.64M Buy
5,243
+86
+2% +$77.3K 0.93% 40
2024
Q2
$4.67M Buy
5,157
+212
+4% +$170K 1.08% 34
2024
Q1
$3.85M Sell
4,945
-24
-0.5% -$17.1K 0.94% 40
2023
Q4
$2.9M Buy
+4,969
New +$2.9M 0.85% 38

Other funds holding LLY

Turtle Creek Wealth Advisors's LLY Position: Q3 2026 in Review

Turtle Creek Wealth Advisors increased its Eli Lilly (LLY) stake by 3% in Q3 2026, buying an estimated $970K and bringing the position to 28,640 shares worth $33.1M. The position accounts for 1.67% of the portfolio, ranked #12.

Turtle Creek Wealth Advisors first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. The position peaked at $33.4M in Q2 2026. 4,568 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Turtle Creek Wealth Advisors held 28,640 shares of Eli Lilly worth $33.1M as of Q3 2026.
  • Turtle Creek Wealth Advisors bought 822 Eli Lilly shares in Q3 2026, an estimated $970K.
  • Eli Lilly made up 1.67% of Turtle Creek Wealth Advisors's portfolio in Q3 2026, its #12 holding.
  • Turtle Creek Wealth Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • Turtle Creek Wealth Advisors's Eli Lilly position peaked at $33.4M in Q2 2026.
  • 4,568 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Turtle Creek Wealth Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.